For the quarter ending 2025-09-30, IMRX has $241,056,266 in assets. $13,079,834 in debts. $227,563,077 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 227,563,077 | 26,355,498 | ||
| Prepaids and other current assets | 1,538,752 | 1,369,928 | ||
| Total current assets | 229,101,829 | 27,725,426 | ||
| Property and equipment, net | 892,553 | 964,138 | ||
| Goodwill | 6,690,431 | 6,690,431 | ||
| Intangible asset, net | 328,463 | 335,780 | ||
| Right-of-use assets | 3,411,693 | 3,498,967 | ||
| Other assets | 631,297 | 841,726 | ||
| Total assets | 241,056,266 | 40,056,468 | ||
| Accounts payable | 1,600,274 | 2,395,203 | ||
| Accrued expenses | 7,483,142 | 4,514,960 | ||
| Other liabilities | 80,089 | 209,708 | ||
| Lease liabilities | 381,760 | 366,959 | ||
| Total current liabilities | 9,545,265 | 7,486,830 | ||
| Lease liabilities, net of current portion | 3,534,569 | 3,633,601 | ||
| Total liabilities | 13,079,834 | 11,120,431 | ||
| Common stock-Common Class A | 63,483 | 35,987 | ||
| Common stock-Common Class B | 0 | 0 | ||
| Additional paid-in capital | 496,653,023 | 282,675,249 | ||
| Accumulated deficit | -268,740,074 | -253,775,199 | ||
| Total stockholders' equity | 227,976,432 | 28,936,037 | ||
| Total liabilities and stockholders' equity | 241,056,266 | 40,056,468 | ||
Immuneering Corp (IMRX)
Immuneering Corp (IMRX)